Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. Issue 2 (December 2015)

• Record Type: Journal Article
• Authors: Ahmed, Nabil; Brawley, Vita; Hegde, Meenakshi; Bielamowicz, Kevin; Wakefield, Amanda; Ghazi, Alexia; Ashoori, Aidin; Diouf, Oumar; Gerken, Claudia; Landi, Daniel; Kalra, Mamta; Yi, Zhongzhen; Rooney, Cliona; Dotti, Gianpietro; Gee, Adrian; Heslop, Helen; Gottschalk, Stephen; Powell, Suzanne; Grossman, Robert; Wels, Winfried; Kew, Yzonne; Baskin, David; Zhang, Jonathan; New, Pamela; Hicks, John
• Is Part Of: Journal for immunotherapy of cancer. Volume 3:Issue 2(2015)
• Page Start: 1
• Page End: 1
• Publication Date: 2015-12
• Subjects: Cancer -- Immunotherapy -- Periodicals; Cancer -- Immunological aspects -- Periodicals; Tumors -- Immunological aspects -- Periodicals; Immunotherapy -- Periodicals; 616.99406105
• DOI: 10.1186/2051-1426-3-S2-O11
• Languages: English
• ISSNs: 2051-1426